Mucocutaneous leishmaniasis (MCL) is a rare and challenging clinical presentation of tegumentary leishmaniasis, primarily affecting the mucosal surfaces of the upper airway. It is often misdiagnosed due to its non-specific symptoms, which can mimic inflammatory, infectious, or neoplastic conditions. This study reports three autochthonous cases of MCL diagnosed between 2023 and 2024. The patients presented chronic symptoms such as dysphagia, odynophagia, lip edema, and ulcerative mucosal lesions. Diagnosis was established through mucosal biopsies, revealing intracellular Leishmania amastigotes via histopathological examination. Treatment varied across the cases and included liposomal Amphotericin B, Meglumine Antimoniate, and Miltefosine, reflecting the complexity of managing MCL. All patients achieved complete clinical remission after individualized therapeutic regimens and careful follow-up. These cases emphasize the importance of considering MCL in the differential diagnosis of persistent upper airway lesions in endemic regions. Early and accurate diagnosis, coupled with tailored treatment strategies, is essential for preventing disease progression and achieving successful clinical outcomes. Furthermore, these findings underscore the need for heightened clinical awareness and multidisciplinary collaboration in managing this rare but significant disease presentation.
{"title":"Mucocutaneous leishmaniasis with upper airway involvement: A report of three cases","authors":"Jaume Fiol Roig , Amaya Roldan Fidalgo , Fabián García Velasco , Meritxell Tomás Fernández , Daniela Mendizábal Cajal","doi":"10.1016/j.otoeng.2025.512276","DOIUrl":"10.1016/j.otoeng.2025.512276","url":null,"abstract":"<div><div>Mucocutaneous leishmaniasis (MCL) is a rare and challenging clinical presentation of tegumentary leishmaniasis, primarily affecting the mucosal surfaces of the upper airway. It is often misdiagnosed due to its non-specific symptoms, which can mimic inflammatory, infectious, or neoplastic conditions. This study reports three autochthonous cases of MCL diagnosed between 2023 and 2024. The patients presented chronic symptoms such as dysphagia, odynophagia, lip edema, and ulcerative mucosal lesions. Diagnosis was established through mucosal biopsies, revealing intracellular <em>Leishmania</em> amastigotes via histopathological examination. Treatment varied across the cases and included liposomal Amphotericin B, Meglumine Antimoniate, and Miltefosine, reflecting the complexity of managing MCL. All patients achieved complete clinical remission after individualized therapeutic regimens and careful follow-up. These cases emphasize the importance of considering MCL in the differential diagnosis of persistent upper airway lesions in endemic regions. Early and accurate diagnosis, coupled with tailored treatment strategies, is essential for preventing disease progression and achieving successful clinical outcomes. Furthermore, these findings underscore the need for heightened clinical awareness and multidisciplinary collaboration in managing this rare but significant disease presentation.</div></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"77 1","pages":"Article 512276"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145058835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.otoeng.2025.512288
Mayada Elsherif , Alia Elkaraksy , Dalia Eldeeb , Mirhan Eldeeb
Introduction and objectives
The diagnostic accuracy and reliability of the head pitch test in differentiating between different types of BPPV require further investigation. Studying the diagnostic accuracy of the head pitch test in BPPV diagnosis can aid in the development of targeted management strategies for patients presenting with BPPV.
Methods
All patients who complained of positional vertigo for seconds underwent complete videonystagmography test using ICS Chartr 200 VNG/ENG system (Otometrics, Denmark) including : spontaneous nystagmus, complete occulomotor test battery, then the head pitch test was performed in two positions: first the patient’s head was bent 90 degrees forwards, then 60 degrees backwards for approximately 1 min each. If nystagmus was observed, its direction was recorded.1 All patients then underwent gold standard tests for positional vertigo including both Dix-Hallpike maneuver and the supine roll tests.
Results
The sensitivity (true positive cases) was defined as the head pitch (HPT) test being positive and showing the correct nystagmus for different categories of BPPV. The sensitivity of the experimental HPT was compared to the gold standard tests (100% sensitive) for diagnosis of different categories of vertical canal and lateral canal BPPV. It was highest (100%) for Lateral Cupulolithiasis patients (n = 12) and Anterior canal Canalithiasis (n = 3) and lowest (68%) for Typical Posterior Canalithiasis patients (n = 68).
Conclusion
This study supports the addition of the head pitch test in the routine assessment of patients with positional vertigo. As it could shorten the examination time and decrease the repositioning maneuvers which may cause severe autonomic symptoms.
{"title":"Diagnostic accuracy of the head pitch test in benign paroxysmal positional vertigo","authors":"Mayada Elsherif , Alia Elkaraksy , Dalia Eldeeb , Mirhan Eldeeb","doi":"10.1016/j.otoeng.2025.512288","DOIUrl":"10.1016/j.otoeng.2025.512288","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>The diagnostic accuracy and reliability of the head pitch test in differentiating between different types of BPPV require further investigation. Studying the diagnostic accuracy of the head pitch test in BPPV diagnosis can aid in the development of targeted management strategies for patients presenting with BPPV.</div></div><div><h3>Methods</h3><div>All patients who complained of positional vertigo for seconds underwent complete videonystagmography test using ICS Chartr 200 VNG/ENG system (Otometrics, Denmark) including : spontaneous nystagmus, complete occulomotor test battery, then the head pitch test was performed in two positions: first the patient’s head was bent 90 degrees forwards, then 60 degrees backwards for approximately 1 min each. If nystagmus was observed, its direction was recorded.<span><span><sup>1</sup></span></span> All patients then underwent gold standard tests for positional vertigo including both Dix-Hallpike maneuver and the supine roll tests.</div></div><div><h3>Results</h3><div>The sensitivity (true positive cases) was defined as the head pitch (HPT) test being positive and showing the correct nystagmus for different categories of BPPV. The sensitivity of the experimental HPT was compared to the gold standard tests (100% sensitive) for diagnosis of different categories of vertical canal and lateral canal BPPV. It was highest (100%) for Lateral Cupulolithiasis patients (<em>n</em> = 12) and Anterior canal Canalithiasis (<em>n</em> = 3) and lowest (68%) for Typical Posterior Canalithiasis patients (<em>n</em> = 68).</div></div><div><h3>Conclusion</h3><div>This study supports the addition of the head pitch test in the routine assessment of patients with positional vertigo. As it could shorten the examination time and decrease the repositioning maneuvers which may cause severe autonomic symptoms.</div></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"77 1","pages":"Article 512288"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145246055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.otoeng.2025.512275
Juan Ramón Gras-Cabrerizo , Juan Carlos Villatoro-Sologaistoa , Maria Casasayas-Plass , María Martel-Martín , Carolina Alfonso-Carrillo , Miguel Armengot-Carceller , María Sandra Domínguez-Sosa , Rafael Fernandez-Liesa , Ainhoa García-Lliberós , María Gil-Melcón , Xavier González-Compta , Fernando López-Álvarez , Mauricio López-Chacón , David Lobo-Duro , Nieves Mata-Castro , Irene Monjas-Cánovas , Ramon Moreno-Luna , Laura Pardo-Muñoz , Mayte Pinilla-Urraca , Alfonso Santamaría-Gadea , Isam Alobid
Introduction
Advances in endonasal endoscopic surgery have highlighted the need to unify and adapt sinonasal anatomical terminology. This study aims to translate and validate the anatomical terms proposed by the European Rhinologic Society into Spanish, in order to facilitate their use and dissemination.
Methods
A Delphi methodology was employed, involving 24 nationally recognised rhinologists with extensive experience in endoscopic surgery. In the first round, Spanish equivalents were proposed for the 121 concepts included in the EPOS (European Position Paper on the Anatomical Terminology) supplement. In the second round, each participant selected a single preferred term among the most voted options. Finally, a panel of seven national experts reviewed and approved the definitive terms, including additional concepts not previously addressed in reference documents.
Results
In 61% (73/121) of the concepts, the expert panel ratified the term most voted by the group of rhinologists. In 31% (38/121), the most voted term was modified, and in 8% (10/121), a final decision was made in the event of a tie. The use of eponyms and latinisms was avoided whenever possible. The terminology selected aimed to accurately reflect the corresponding anatomical concepts. Moreover, relevant terms not included in the EPOS consensus documents or the Anatomical Terminology were incorporated.
Conclusion
The adaptation and validation of sinonasal anatomical terminology into Spanish enhances international communication and contributes to improving clinical practice in rhinology.
{"title":"Standardisation of sinonasal anatomical terminology in Spanish: An expert consensus","authors":"Juan Ramón Gras-Cabrerizo , Juan Carlos Villatoro-Sologaistoa , Maria Casasayas-Plass , María Martel-Martín , Carolina Alfonso-Carrillo , Miguel Armengot-Carceller , María Sandra Domínguez-Sosa , Rafael Fernandez-Liesa , Ainhoa García-Lliberós , María Gil-Melcón , Xavier González-Compta , Fernando López-Álvarez , Mauricio López-Chacón , David Lobo-Duro , Nieves Mata-Castro , Irene Monjas-Cánovas , Ramon Moreno-Luna , Laura Pardo-Muñoz , Mayte Pinilla-Urraca , Alfonso Santamaría-Gadea , Isam Alobid","doi":"10.1016/j.otoeng.2025.512275","DOIUrl":"10.1016/j.otoeng.2025.512275","url":null,"abstract":"<div><h3>Introduction</h3><div>Advances in endonasal endoscopic surgery have highlighted the need to unify and adapt sinonasal anatomical terminology. This study aims to translate and validate the anatomical terms proposed by the European Rhinologic Society into Spanish, in order to facilitate their use and dissemination.</div></div><div><h3>Methods</h3><div>A Delphi methodology was employed, involving 24 nationally recognised rhinologists with extensive experience in endoscopic surgery. In the first round, Spanish equivalents were proposed for the 121 concepts included in the <em>EPOS</em> (<em>European Position Paper on the Anatomical Terminology</em>) supplement. In the second round, each participant selected a single preferred term among the most voted options. Finally, a panel of seven national experts reviewed and approved the definitive terms, including additional concepts not previously addressed in reference documents.</div></div><div><h3>Results</h3><div>In 61% (73/121) of the concepts, the expert panel ratified the term most voted by the group of rhinologists. In 31% (38/121), the most voted term was modified, and in 8% (10/121), a final decision was made in the event of a tie. The use of eponyms and latinisms was avoided whenever possible. The terminology selected aimed to accurately reflect the corresponding anatomical concepts. Moreover, relevant terms not included in the <em>EPOS</em> consensus documents or the <em>Anatomical Terminology</em> were incorporated.</div></div><div><h3>Conclusion</h3><div>The adaptation and validation of sinonasal anatomical terminology into Spanish enhances international communication and contributes to improving clinical practice in rhinology.</div></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"77 1","pages":"Article 512275"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145214711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.otoeng.2025.512292
Ángel Ángel de Miguel , Atilio Navarro , Moisés Sánchez Pardo , Ainhoa García-Lliberós
{"title":"Malignant sinonasal paraganglioma: A major clinical and histopathological challenge in a rare entity","authors":"Ángel Ángel de Miguel , Atilio Navarro , Moisés Sánchez Pardo , Ainhoa García-Lliberós","doi":"10.1016/j.otoeng.2025.512292","DOIUrl":"10.1016/j.otoeng.2025.512292","url":null,"abstract":"","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"77 1","pages":"Article 512292"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145472578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.otoeng.2025.512309
María Agustina Sevilla García , Carlos Miguel Chiesa-Estomba , Luz Barona-Lleó , Ángel Álvarez Sánchez , Carlos Martín de Argila
Introduction
Laryngopharyngeal reflux (LPR) represents a diagnostic and therapeutic challenge due to the nonspecific nature of its clinical manifestations and the absence of objective biomarkers. The aim of this work is to establish a national consensus on its definition, diagnosis, and treatment through a modified Delphi methodology that integrates the perspectives of otolaryngologists (ENT) and gastroenterologists (GI).
Materials and methods
A scientific committee composed of three ENTs and two GIs developed 117 items distributed across seven thematic sections. The Delphi process involved 73 panellists in the first round, of whom 65 (89%) completed both rounds of voting. Participants were representative of the Spanish autonomous communities, with an average of 17 years of clinical experience and a multidisciplinary profile (63.1% ENT; 36.9% GI).
Results
After two rounds of voting, positive consensus was reached on 76 items (64.9%), distributed as follows: 14 on definition and pathophysiology; 12 on symptoms and pharyngeal findings; 2 on associations with other ENT diseases; 10 on diagnostic methods; 3 on validated questionnaires; 15 on treatment and recommendations; and 11 on clinical follow-up.
Conclusion
The results of the consensus reflect the suitability and effectiveness of the Delphi methodology used to create a consensus document on the definition, presentation, diagnosis, and management of a condition that until now has been poorly defined, such as LPR. The aim is to support specialists in their daily clinical practice, and unlike previous efforts, it has succeeded in unifying within a single document the criteria of the two specialties most involved in managing these patients.
{"title":"Spanish multidisciplinary Consensus on the diagnosis and management of laryngopharyngeal reflux (ReFaL Consensus)","authors":"María Agustina Sevilla García , Carlos Miguel Chiesa-Estomba , Luz Barona-Lleó , Ángel Álvarez Sánchez , Carlos Martín de Argila","doi":"10.1016/j.otoeng.2025.512309","DOIUrl":"10.1016/j.otoeng.2025.512309","url":null,"abstract":"<div><h3>Introduction</h3><div>Laryngopharyngeal reflux (LPR) represents a diagnostic and therapeutic challenge due to the nonspecific nature of its clinical manifestations and the absence of objective biomarkers. The aim of this work is to establish a national consensus on its definition, diagnosis, and treatment through a modified Delphi methodology that integrates the perspectives of otolaryngologists (ENT) and gastroenterologists (GI).</div></div><div><h3>Materials and methods</h3><div>A scientific committee composed of three ENTs and two GIs developed 117 items distributed across seven thematic sections. The Delphi process involved 73 panellists in the first round, of whom 65 (89%) completed both rounds of voting. Participants were representative of the Spanish autonomous communities, with an average of 17 years of clinical experience and a multidisciplinary profile (63.1% ENT; 36.9% GI).</div></div><div><h3>Results</h3><div>After two rounds of voting, positive consensus was reached on 76 items (64.9%), distributed as follows: 14 on definition and pathophysiology; 12 on symptoms and pharyngeal findings; 2 on associations with other ENT diseases; 10 on diagnostic methods; 3 on validated questionnaires; 15 on treatment and recommendations; and 11 on clinical follow-up.</div></div><div><h3>Conclusion</h3><div>The results of the consensus reflect the suitability and effectiveness of the Delphi methodology used to create a consensus document on the definition, presentation, diagnosis, and management of a condition that until now has been poorly defined, such as LPR. The aim is to support specialists in their daily clinical practice, and unlike previous efforts, it has succeeded in unifying within a single document the criteria of the two specialties most involved in managing these patients.</div></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"77 1","pages":"Article 512309"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145758641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This study evaluates the impact of cochlear implantation on cognitive function in older adults, focusing on executive function, processing speed, and memory.
Methods
A prospective observational study was conducted on 15 older adults (mean age: 72.4 years) who underwent cochlear implantation at the ENT and Head and Neck Surgery Department. Cognitive function was assessed using the Mini-Mental State Examination (MMSE) and the Trail Making Test (TMT-A and TMT-B) pre- and post-implantation (6 and 12 months). Results were compared using statistical analyses, and correlations between cognitive improvement and speech perception outcomes were examined.
Results
Cognitive function significantly improved post-implantation, with MMSE scores increasing from 22.93 ± 3.2 at baseline to 24.6 ± 2.9 at 12 months (p < 0.05). TMT-A and TMT-B scores also improved significantly (p < 0.05), indicating enhanced executive function and processing speed. A moderate correlation (r = 0.52, p = 0.04) was observed between cognitive improvement and speech perception.
Conclusion
These findings support the hypothesis that cochlear implantation in older adults positively impacts cognitive function. This study adds to the growing body of evidence suggesting that auditory rehabilitation may help mitigate cognitive decline in aging populations.
{"title":"Impact of cochlear implants on cognitive performance during aging","authors":"Fatima Ezzahra Rizkou , Youssef Lakhdar , Omar Oulghoul , Mohammed Chehbouni , Othmane Benhoummad , Youssef Rochdi , Abdelaziz Raji","doi":"10.1016/j.otoeng.2025.512289","DOIUrl":"10.1016/j.otoeng.2025.512289","url":null,"abstract":"<div><h3>Objective</h3><div>This study evaluates the impact of cochlear implantation on cognitive function in older adults, focusing on executive function, processing speed, and memory.</div></div><div><h3>Methods</h3><div>A prospective observational study was conducted on 15 older adults (mean age: 72.4 years) who underwent cochlear implantation at the ENT and Head and Neck Surgery Department. Cognitive function was assessed using the Mini-Mental State Examination (MMSE) and the Trail Making Test (TMT-A and TMT-B) pre- and post-implantation (6 and 12 months). Results were compared using statistical analyses, and correlations between cognitive improvement and speech perception outcomes were examined.</div></div><div><h3>Results</h3><div>Cognitive function significantly improved post-implantation, with MMSE scores increasing from 22.93 ± 3.2 at baseline to 24.6 ± 2.9 at 12 months (<em>p < 0.05</em>). TMT-A and TMT-B scores also improved significantly (<em>p < 0.05</em>), indicating enhanced executive function and processing speed. A moderate correlation (<em>r = 0.52, p = 0.04</em>) was observed between cognitive improvement and speech perception.</div></div><div><h3>Conclusion</h3><div>These findings support the hypothesis that cochlear implantation in older adults positively impacts cognitive function. This study adds to the growing body of evidence suggesting that auditory rehabilitation may help mitigate cognitive decline in aging populations.</div></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"77 1","pages":"Article 512289"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145246075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.otoeng.2025.512287
Abobakr Mohammed Elbakry , Ahmed Nabil Selim , Alaa Abdelwahab Eldarawy , Abdallah Mahmoud Gad
Objectives
The aim of the study is comparing endoscopic coblation adenoidectomy and suction diathermy in terms of surgical duration, intraoperative blood loss, and postoperative complications such as foul odor, neck pain, and secondary bleeding, as well as patient recovery.
Patients and methods
Prospective randomized double blinded controlled trial involving 210 patients who presented with adenoid hypertrophy. Randomization was done in two groups group A including 105 patients who underwent endoscopic adenoidectomy by suction diathermy, Group B including 105 patients who underwent endoscopic adenoidectomy by coblation technique.
Patients were compared regarding intraoperative blood loss and operative time and postoperative bleeding, postoperative neck pain, and halitosis.
Results
When comparing the two groups, Group B had notably longer surgeries but experienced less pain after the operation, recovered more quickly, and had a lower chance of bad breath. There was no significant difference between both the groups regarding intraoperative blood loss.
Conclusion
Both techniques are effective in management of adenoid hypertrophy, but results showed endoscopic adenoidectomy with coblation is favored over suction diathermy due to better postoperative outcomes.
{"title":"Coblation versus suction Diathermy in Endoscopic Pediatric Adenoidectomy: Randomized clinical trial","authors":"Abobakr Mohammed Elbakry , Ahmed Nabil Selim , Alaa Abdelwahab Eldarawy , Abdallah Mahmoud Gad","doi":"10.1016/j.otoeng.2025.512287","DOIUrl":"10.1016/j.otoeng.2025.512287","url":null,"abstract":"<div><h3>Objectives</h3><div>The aim of the study is comparing endoscopic coblation adenoidectomy and suction diathermy in terms of surgical duration, intraoperative blood loss, and postoperative complications such as foul odor, neck pain, and secondary bleeding, as well as patient recovery.</div></div><div><h3>Patients and methods</h3><div>Prospective randomized double blinded controlled trial involving 210 patients who presented with adenoid hypertrophy. Randomization was done in two groups group A including 105 patients who underwent endoscopic adenoidectomy by suction diathermy, Group B including 105 patients who underwent endoscopic adenoidectomy by coblation technique.</div><div>Patients were compared regarding intraoperative blood loss and operative time and postoperative bleeding, postoperative neck pain, and halitosis.</div></div><div><h3>Results</h3><div>When comparing the two groups, Group B had notably longer surgeries but experienced less pain after the operation, recovered more quickly, and had a lower chance of bad breath. There was no significant difference between both the groups regarding intraoperative blood loss.</div></div><div><h3>Conclusion</h3><div>Both techniques are effective in management of adenoid hypertrophy, but results showed endoscopic adenoidectomy with coblation is favored over suction diathermy due to better postoperative outcomes.</div></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"77 1","pages":"Article 512287"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145240357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.otoeng.2025.512293
Eduardo Lehrer , Tomeu Alberto , Ada Cabero , Mónica Egea , Marina Paredes , Sara Jubés , Isabel Vilaseca
Background and objectives
The 445 nm blue laser has expanded therapeutic possibilities in the office. However, comparative studies with laser surgery in the operating theatre are scarce. The present study aims to analyse both techniques applied to the treatment of benign laryngeal lesions in terms of efficacy, tolerability, and efficiency.
Materials and methods
Prospective, non-randomised observational study of 93 consecutive patients with benign laryngeal lesions treated in the office (TNFLS) or in the operating theatre using transoral blue laser microsurgery (TOBLM), (48 TNFLS, 38 TOBLM, 7 combined cases). Vocal outcomes were assessed using the abbreviated vocal handicap index (VHI-10), a visual analogue scale (VAS) and the acoustic voice quality index (AVQI) obtained from acoustic analysis, as well as the tolerability and efficiency of the procedures. The variables were evaluated before and 3 months after surgery.
Results
Both groups showed improvements at 3 months postoperatively in VHI-10, VAS, and AVQI, with no differences between techniques. TNFLS had a high tolerability rate (95.4%) and was significantly more cost-effective, with a cost-per-point of improvement in the VHI-10 of €86.30 vs. €200.42.
Conclusions
TNFLS with blue laser is an effective, well-tolerated, and cost-effective alternative to conventional surgery for benign laryngeal lesions. These results support its implementation in dynamic healthcare settings that prioritize efficiency.
{"title":"From the operating theatre to the office: Functional outcomes, tolerability, and cost-effectiveness of the blue laser in benign laryngeal surgery","authors":"Eduardo Lehrer , Tomeu Alberto , Ada Cabero , Mónica Egea , Marina Paredes , Sara Jubés , Isabel Vilaseca","doi":"10.1016/j.otoeng.2025.512293","DOIUrl":"10.1016/j.otoeng.2025.512293","url":null,"abstract":"<div><h3>Background and objectives</h3><div>The 445 nm blue laser has expanded therapeutic possibilities in the office. However, comparative studies with laser surgery in the operating theatre are scarce. The present study aims to analyse both techniques applied to the treatment of benign laryngeal lesions in terms of efficacy, tolerability, and efficiency.</div></div><div><h3>Materials and methods</h3><div>Prospective, non-randomised observational study of 93 consecutive patients with benign laryngeal lesions treated in the office (TNFLS) or in the operating theatre using transoral blue laser microsurgery (TOBLM), (48 TNFLS, 38 TOBLM, 7 combined cases). Vocal outcomes were assessed using the abbreviated vocal handicap index (VHI-10), a visual analogue scale (VAS) and the acoustic voice quality index (AVQI) obtained from acoustic analysis, as well as the tolerability and efficiency of the procedures. The variables were evaluated before and 3 months after surgery.</div></div><div><h3>Results</h3><div>Both groups showed improvements at 3 months postoperatively in VHI-10, VAS, and AVQI, with no differences between techniques. TNFLS had a high tolerability rate (95.4%) and was significantly more cost-effective, with a cost-per-point of improvement in the VHI-10 of €86.30 vs. €200.42.</div></div><div><h3>Conclusions</h3><div>TNFLS with blue laser is an effective, well-tolerated, and cost-effective alternative to conventional surgery for benign laryngeal lesions. These results support its implementation in dynamic healthcare settings that prioritize efficiency.</div></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"77 1","pages":"Article 512293"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145472610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-12DOI: 10.1016/j.otoeng.2025.512312
Carlota Rovira-Martínez, Mariana Campos-Motamayor, Aina Sansa-Perna, Elios Yuste, Laura Gelabert, Josep de Haro-Licer, Alda Cardesín-Revilla, Miguel Caballero-Borrego
Background and objectives: Post-COVID-19 olfactory dysfunction persists in many patients and significantly affects quality of life. The primary objective was to evaluate olfactory function using psychophysical tests (BAST-24) and quality-of-life questionnaires. Secondary objectives included analysing correlations between questionnaires and the relationship between subjective and psychophysical measures.
Materials and methods: A prospective study was conducted including 86 adults with olfactory dysfunction ≥ 6 months after SARS-CoV-2 infection. Clinical and demographic data and scores from the Visual Analog Scale for smell (VAS-smell) and the SNOT-22, svQOD-NS, and QVOLF questionnaires were collected. Olfactory function was assessed using the BAST-24 (detection, identification, and olfactory memory). Descriptive statistics, Spearman's correlation coefficient, and the Mann-Whitney U test were used (p < 0.05).
Results: Mean age was 49 years (SD = 14); 76.7% were women. According to the VAS, 90.7% had hyposmia and 8.1% anosmia. Mean scores (SD) were: VAS 6 (2), SNOT-22 26 (20), svQOD-NS 4 (4), and QVOLF 127 (50), suggesting a moderate impact on quality of life. BAST-24 scores: detection 91% (22), identification 52% (25), and memory 35% (20). QVOLF and svQOD-NS showed a strong correlation (ρ = 0.797; p < 0.001), while SNOT-22 correlated moderately with both. No significant correlations were found between any questionnaire and BAST-24.
Conclusions: QVOLF and svQOD-NS questionnaires are more sensitive than SNOT-22 for assessing olfactory dysfunction. The lack of correlation with psychophysical tests highlights the need to combine both approaches fora comprehensive evaluation.
{"title":"Assessment of the impact of post-COVID-19 olfactory dysfunction on quality of life: Comparison of specific questionnaires.","authors":"Carlota Rovira-Martínez, Mariana Campos-Motamayor, Aina Sansa-Perna, Elios Yuste, Laura Gelabert, Josep de Haro-Licer, Alda Cardesín-Revilla, Miguel Caballero-Borrego","doi":"10.1016/j.otoeng.2025.512312","DOIUrl":"10.1016/j.otoeng.2025.512312","url":null,"abstract":"<p><strong>Background and objectives: </strong>Post-COVID-19 olfactory dysfunction persists in many patients and significantly affects quality of life. The primary objective was to evaluate olfactory function using psychophysical tests (BAST-24) and quality-of-life questionnaires. Secondary objectives included analysing correlations between questionnaires and the relationship between subjective and psychophysical measures.</p><p><strong>Materials and methods: </strong>A prospective study was conducted including 86 adults with olfactory dysfunction ≥ 6 months after SARS-CoV-2 infection. Clinical and demographic data and scores from the Visual Analog Scale for smell (VAS-smell) and the SNOT-22, svQOD-NS, and QVOLF questionnaires were collected. Olfactory function was assessed using the BAST-24 (detection, identification, and olfactory memory). Descriptive statistics, Spearman's correlation coefficient, and the Mann-Whitney U test were used (p < 0.05).</p><p><strong>Results: </strong>Mean age was 49 years (SD = 14); 76.7% were women. According to the VAS, 90.7% had hyposmia and 8.1% anosmia. Mean scores (SD) were: VAS 6 (2), SNOT-22 26 (20), svQOD-NS 4 (4), and QVOLF 127 (50), suggesting a moderate impact on quality of life. BAST-24 scores: detection 91% (22), identification 52% (25), and memory 35% (20). QVOLF and svQOD-NS showed a strong correlation (ρ = 0.797; p < 0.001), while SNOT-22 correlated moderately with both. No significant correlations were found between any questionnaire and BAST-24.</p><p><strong>Conclusions: </strong>QVOLF and svQOD-NS questionnaires are more sensitive than SNOT-22 for assessing olfactory dysfunction. The lack of correlation with psychophysical tests highlights the need to combine both approaches fora comprehensive evaluation.</p>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":" ","pages":"512312"},"PeriodicalIF":0.0,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145758586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-05DOI: 10.1016/j.otoeng.2025.512310
María Alharilla Montilla-Ibáñez, Javier Modesto García-Fernández, M S Sánchez-Torices, M P Gómez-Gallego, M A Feliz-Fernández, R Lomas-Vega
Introduction: To perform the cross-cultural adaptation into Spanish and the psychometric validation of the Nasal Polyposis Quality of Life Questionnaire (NPQ) for use in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).
Methods: A total of 140 adult patients diagnosed with CRSwNP were included. The original NPQ was adapted from Italian into Spanish following established international guidelines. Construct validity was assessed through exploratory factor analysis (EFA) with principal components. Internal consistency was analyzed using Cronbach's alpha coefficient. Test-retest reliability was determined by the intraclass correlation coefficient (ICC). Concurrent validity was examined using Pearson correlations with the SNOT-22 and NOSE-E questionnaires. Discriminant validity was analyzed using ROC curves.
Results: EFA revealed a five-factor structure explaining 67% of the total variance. The Spanish NPQ showed excellent internal consistency (Cronbach's α = 0.917) and high test-retest reliability (ICC = 0.991; 95% CI: 0.983-0.996). The standard error of measurement (SEM) was 2 points, and the minimal detectable change (MDC95) was 5 points. Strong correlations were observed with the NOSE-E (r = 0.802) and SNOT-22 (r = 0.870). The NPQ total score demonstrated high discriminative ability for severe symptoms (AUC = 0.947), with a cutoff point >41 providing 88.9% sensitivity and 93.3% specificity.
Conclusions: The Spanish version of the NPQ is a valid, reliable, and clinically useful instrument for assessing symptom burden in patients with CRSwNP. Its multidimensional structure allows capturing the specific impact of this phenotype and supports its use in both clinical practice and research.
{"title":"Cross-cultural adaptation and psychometric validation of the Spanish version of the Nasal Polyposis Quality of Life Questionnaire (NPQ).","authors":"María Alharilla Montilla-Ibáñez, Javier Modesto García-Fernández, M S Sánchez-Torices, M P Gómez-Gallego, M A Feliz-Fernández, R Lomas-Vega","doi":"10.1016/j.otoeng.2025.512310","DOIUrl":"10.1016/j.otoeng.2025.512310","url":null,"abstract":"<p><strong>Introduction: </strong>To perform the cross-cultural adaptation into Spanish and the psychometric validation of the Nasal Polyposis Quality of Life Questionnaire (NPQ) for use in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).</p><p><strong>Methods: </strong>A total of 140 adult patients diagnosed with CRSwNP were included. The original NPQ was adapted from Italian into Spanish following established international guidelines. Construct validity was assessed through exploratory factor analysis (EFA) with principal components. Internal consistency was analyzed using Cronbach's alpha coefficient. Test-retest reliability was determined by the intraclass correlation coefficient (ICC). Concurrent validity was examined using Pearson correlations with the SNOT-22 and NOSE-E questionnaires. Discriminant validity was analyzed using ROC curves.</p><p><strong>Results: </strong>EFA revealed a five-factor structure explaining 67% of the total variance. The Spanish NPQ showed excellent internal consistency (Cronbach's α = 0.917) and high test-retest reliability (ICC = 0.991; 95% CI: 0.983-0.996). The standard error of measurement (SEM) was 2 points, and the minimal detectable change (MDC95) was 5 points. Strong correlations were observed with the NOSE-E (r = 0.802) and SNOT-22 (r = 0.870). The NPQ total score demonstrated high discriminative ability for severe symptoms (AUC = 0.947), with a cutoff point >41 providing 88.9% sensitivity and 93.3% specificity.</p><p><strong>Conclusions: </strong>The Spanish version of the NPQ is a valid, reliable, and clinically useful instrument for assessing symptom burden in patients with CRSwNP. Its multidimensional structure allows capturing the specific impact of this phenotype and supports its use in both clinical practice and research.</p>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":" ","pages":"512310"},"PeriodicalIF":0.0,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145703085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号